FDA issued a Warning Letter to Malladi Drugs & Pharmaceuticals Ltd. on 3/9/2018 as a result of this inspection.
483 Malladi Drugs & Pharmaceuticals Sep 2017

483 Malladi Drugs & Pharmaceuticals Sep 2017

Linda Murphy FDA$119.00 - Available Now

FDA investigators audited the Malladi Drugs & Pharmaceuticals - Ranipet, India facility and issued inspectional observations (via FDA 483) on 08 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 08 Sep 2017
  • Location: Ranipet, India
  • FEI: 3005115135
Add To Cart